Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Business Practice, Trends & Forecasts

Eyes on Expansion

Summer is the season for sun, sea, sand… And a raft of new and expanded manufacturing plants. May and June have seen something of an expansion craze with companies big and small announcing new investments – and biologics seem to be a key focus.

AstraZeneca says that biotech products now make up half of its pipeline and recently announced that it was investing $285-million in a new plant for filling and packaging protein therapeutics in Södertälje, Sweden. By the end of 2018, the facility is expected to supply biologic medicines for AstraZeneca and MedImmune’s clinical trial programmes, moving on to commercial products once fully operational in 2019. The company also bolstered its biologics manufacturing capabilities in the US at the end of 2014 with a $200-million project to expand its Frederick, Maryland site, which currently produces pediatric medications and investigational biologic products. But small molecules have not been entirely forgotten; in June, AstraZeneca  announced that was partnering with two Algerian companies to create a new plant for small molecules in Algeria.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Stephanie Sutton

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent seven years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register